Literature DB >> 19681060

N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity.

Aly M Abdelrahman1, Suhail Al Salam, Ahmed S AlMahruqi, Ishaq S Al husseni, Mohamed A Mansour, Badreldin H Ali.   

Abstract

This work investigated the effect of N-acetylcysteine (NAC), on renal hemodynamics in cisplatin (CP)-induced nephrotoxicity in Wistar-Kyoto (WKY) rats. The animals were divided into four groups (n = 5 or 6). The first and second groups received normal saline (control) and intraperitoneal (i.p.) N-acetylcysteine (500 mg kg(-1) per day for 9 days), respectively. The third and fourth groups were given a single intraperitoneal (i.p.) injection of CP (5 mg kg(-1)) and an i.p. injection of CP (5 mg kg(-1)) together with i.p. NAC (500 mg kg(-1) per day for 9 days), respectively. At the end of the experiment, rats were anesthetized and blood pressure and renal blood flow were monitored, followed by intravenous (i.v.) injection of norepinephrine (NE) for measurement of renal vasoconstrictor responses. CP caused a significant reduction in renal blood flow but did not affect NE-induced renal vasoconstriction. In addition, CP significantly increased plasma concentrations of urea and creatinine and urinary N-acetyl-beta-D-glucosaminidase (NAG) activity and kidney relative weight. CP decreased body weight and creatinine clearance. Histopathologically, CP caused remarkable renal damage compared with control. NAC alone did not produce any significant change in any of the variables measured. However, NAC significantly ameliorated CP-induced hemodynamic, biochemical and histopathological changes. The concentration of platinum in the kidneys of CP ? NAC treated rats was less than in CP-treated rats by 37%. The results show that administration of i.p. NAC (500 mg kg(-1) per day for 9 days) reversed the renal hemodynamic changes as well as the biochemical and histopathological indices of CP-induced nephrotoxicity in WKY rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19681060     DOI: 10.1002/jat.1465

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  21 in total

Review 1.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

2.  Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human.

Authors:  Alfeu Zanotto-Filho; Ravi Dashnamoorthy; Eva Loranc; Luis H T de Souza; José C F Moreira; Uthra Suresh; Yidong Chen; Alexander J R Bishop
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

3.  N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial.

Authors:  Iman Karimzadeh; Hossein Khalili; Simin Dashti-Khavidaki; Ramezanali Sharifian; Alireza Abdollahi; Mehrdad Hasibi; Zahra Khazaeipour; Shadi Farsaei
Journal:  Eur J Clin Pharmacol       Date:  2014-01-21       Impact factor: 2.953

4.  The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.

Authors:  Badreldin H Ali; Mohammed Al Za'abi; Asem Shalaby; Priyadarsini Manoj; Mostafa I Waly; Javed Yasin; Mohamed Fahim; Abderrahim Nemmar
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-28

5.  Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis.

Authors:  Xinwen Liu; Zhenguang Huang; Xiaoqin Zou; Yufang Yang; Yue Qiu; Yan Wen
Journal:  Int J Clin Exp Pathol       Date:  2014-11-15

Review 6.  Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.

Authors:  Siddesh Jaiman; Arun Kumar Sharma; Kulwant Singh; Deepa Khanna
Journal:  Eur J Clin Pharmacol       Date:  2013-08-09       Impact factor: 2.953

Review 7.  N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.

Authors:  Hesamoddin Hosseinjani; Azadeh Moghaddas; Hossein Khalili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-19       Impact factor: 2.953

8.  Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury.

Authors:  Subhashini Bolisetty; Amie Traylor; Reny Joseph; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16

9.  Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.

Authors:  Aly M Abdelrahman; Yousuf Al Suleimani; Asem Shalaby; Mohammed Ashique; Priyadarsini Manoj; Abderrahim Nemmar; Badreldin H Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-11       Impact factor: 3.000

10.  Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats.

Authors:  Asmaa Elsayed; Ashraf Elkomy; Reda Elkammar; Gehan Youssef; Ehab Yahya Abdelhiee; Walied Abdo; Sabreen Ezzat Fadl; Ahmed Soliman; Mohamed Aboubakr
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.